CYTOKINETICS INC·4

Oct 21, 6:18 PM ET

Malik Fady Ibraham 4

4 · CYTOKINETICS INC · Filed Oct 21, 2025

Insider Transaction Report

Form 4
Period: 2025-10-21
Malik Fady Ibraham
EVP Research & Development
Transactions
  • Exercise/Conversion

    Common Stock

    2025-10-21$10.60/sh+2,105$22,313142,715 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2025-10-212,1051,000 total
    Exercise: $10.60From: 2017-03-28Exp: 2027-02-28Common Stock (2,105 underlying)
  • Sale

    Common Stock

    2025-10-21$58.22/sh2,105$122,553140,610 total

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT